Ignite Creation Date:
2024-05-06 @ 8:19 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06335160
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-03-28
First Post:
2024-03-21
Brief Title:
Possible Efficacy and Safety of Mebendazole in Patients With Ulcerative Colitis Treated With Mesalamine
Sponsor:
Tanta University
Organization:
Tanta University
Study Overview
Official Title:
Clinical Study to Evaluate the Possible Efficacy and Safety of Mebendazole in Patients With Ulcerative Colitis Treated With Mesalamine
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the possible efficacy and safety of mebendazole in patients with ulcerative colitis treated with mesalamine
Detailed Description:
A randomized controlled and parallel study will comprise 46 patients with UC Patients will be recruited from GastroEnterology Department Mansoura University Hospital
The participants will be randomly assigned into two groups as follow
Group 1 control group Mesalamine group n 23 who will receive 1 g mesalamine three times daily for 6 months
Group 2 mebendazole group n 23 which will receive the standard treatment for UC plus mebendazole 500 mg twice daily for 6 months
The participants will be randomly assigned into two groups as follow
Group 1 control group Mesalamine group n 23 who will receive 1 g mesalamine three times daily for 6 months
Group 2 mebendazole group n 23 which will receive the standard treatment for UC plus mebendazole 500 mg twice daily for 6 months
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None